My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 43

    1.

    The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.

    Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J, Kim YK, Kang J, Park CG, Han JW, Lee HY.

    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.595. [Epub ahead of print]

    PMID:
    22249252
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling.

    Zeller C, Dai W, Steele NL, Siddiq A, Walley AJ, Wilhelm-Benartzi CS, Rizzo S, van der Zee A, Plumb JA, Brown R.

    Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.611. [Epub ahead of print]

    PMID:
    22249249
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.

    Alberti C, Pinciroli P, Valeri B, Ferri R, Ditto A, Umezawa K, Sensi M, Canevari S, Tomassetti A.

    Oncogene. 2011 Dec 12. doi: 10.1038/onc.2011.572. [Epub ahead of print]

    PMID:
    22158046
    [PubMed - as supplied by publisher]

    Related citations

    4.

    A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.

    Ratner ES, Keane FK, Lindner R, Tassi RA, Paranjape T, Glasgow M, Nallur S, Deng Y, Lu L, Steele L, Sand S, Muller RU, Bignotti E, Bellone S, Boeke M, Yao X, Pecorelli S, Ravaggi A, Katsaros D, Zelterman D, Cristea MC, Yu H, Rutherford TJ, Weitzel JN, Neuhausen SL, Schwartz PE, Slack FJ, Santin AD, Weidhaas JB.

    Oncogene. 2011 Dec 5. doi: 10.1038/onc.2011.539. [Epub ahead of print]

    PMID:
    22139083
    [PubMed - as supplied by publisher]

    Related citations

    5.

    Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.

    Cao L, Shao M, Schilder J, Guise T, Mohammad KS, Matei D.

    Oncogene. 2012 May 17;31(20):2521-34. doi: 10.1038/onc.2011.429. Epub 2011 Oct 3.

    PMID:
    21963846
    [PubMed - in process]

    Related citations

    6.

    Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.

    Wang Y, Sheng Q, Spillman MA, Behbakht K, Gu H.

    Oncogene. 2012 May 17;31(20):2512-20. doi: 10.1038/onc.2011.435. Epub 2011 Sep 26.

    PMID:
    21996746
    [PubMed - in process]

    Related citations

    7.

    Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.

    Yue P, Zhang X, Paladino D, Sengupta B, Ahmad S, Holloway RW, Ingersoll SB, Turkson J.

    Oncogene. 2012 May 3;31(18):2309-22. doi: 10.1038/onc.2011.409. Epub 2011 Sep 12.

    PMID:
    21909139
    [PubMed - in process]

    Related citations

    8.

    NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.

    Zhang Y, Cheng Y, Ren X, Zhang L, Yap KL, Wu H, Patel R, Liu D, Qin ZH, Shih IM, Yang JM.

    Oncogene. 2012 Feb 23;31(8):1055-64. doi: 10.1038/onc.2011.290. Epub 2011 Jul 11.

    PMID:
    21743489
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.

    Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, Wang TH, Lai CH.

    Oncogene. 2012 Feb 9;31(6):764-75. doi: 10.1038/onc.2011.269. Epub 2011 Jul 4.

    PMID:
    21725366
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.

    Lau MT, Klausen C, Leung PC.

    Oncogene. 2011 Jun 16;30(24):2753-66. doi: 10.1038/onc.2011.6. Epub 2011 Feb 7.

    PMID:
    21297666
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.

    Badgwell DB, Lu Z, Le K, Gao F, Yang M, Suh GK, Bao JJ, Das P, Andreeff M, Chen W, Yu Y, Ahmed AA, S-L Liao W, Bast RC Jr.

    Oncogene. 2012 Jan 5;31(1):68-79. doi: 10.1038/onc.2011.213. Epub 2011 Jun 6.

    PMID:
    21643014
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells.

    Fu G, Peng C.

    Oncogene. 2011 Sep 15;30(37):3953-66. doi: 10.1038/onc.2011.127. Epub 2011 May 2.

    PMID:
    21532621
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer.

    Reimer D, Hubalek M, Kiefel H, Riedle S, Skvortsov S, Erdel M, Hofstetter G, Concin N, Fiegl H, Müller-Holzner E, Marth C, Altevogt P, Zeimet AG.

    Oncogene. 2011 Sep 22;30(38):4038-49. doi: 10.1038/onc.2011.119. Epub 2011 Apr 25.

    PMID:
    21516127
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.

    Al-Bahlani S, Fraser M, Wong AY, Sayan BS, Bergeron R, Melino G, Tsang BK.

    Oncogene. 2011 Oct 13;30(41):4219-30. doi: 10.1038/onc.2011.134. Epub 2011 Apr 25.

    PMID:
    21516125
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    15.

    MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.

    Zhai Y, Iura A, Yeasmin S, Wiese AB, Wu R, Feng Y, Fearon ER, Cho KR.

    Oncogene. 2011 Oct 6;30(40):4152-62. doi: 10.1038/onc.2011.123. Epub 2011 Apr 18.

    PMID:
    21499300
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    16.

    Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.

    Cheng JC, Auersperg N, Leung PC.

    Oncogene. 2011 Sep 15;30(37):3930-42. doi: 10.1038/onc.2011.117. Epub 2011 Apr 11.

    PMID:
    21478913
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).

    Kim JH, Yoon S, Park M, Park HO, Ko JJ, Lee K, Bae J.

    Oncogene. 2011 Apr 7;30(14):1653-63. Epub 2010 Nov 29.

    PMID:
    21119601
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.

    Mullany LK, Fan HY, Liu Z, White LD, Marshall A, Gunaratne P, Anderson ML, Creighton CJ, Xin L, Deavers M, Wong KK, Richards JS.

    Oncogene. 2011 Aug 11;30(32):3522-36. doi: 10.1038/onc.2011.70. Epub 2011 Mar 21.

    PMID:
    21423204
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    19.

    Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer.

    Charoenfuprasert S, Yang YY, Lee YC, Chao KC, Chu PY, Lai CR, Hsu KF, Chang KC, Chen YC, Chen LT, Chang JY, Leu SJ, Shih NY.

    Oncogene. 2011 Aug 18;30(33):3570-84. doi: 10.1038/onc.2011.77. Epub 2011 Mar 14.

    PMID:
    21399663
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated gene OTAG-12: downregulation, alternative splicing and drug sensitization.

    Chen X, Zhang H, Aravindakshan JP, Gotlieb WH, Sairam MR.

    Oncogene. 2011 Jun 23;30(25):2874-87. doi: 10.1038/onc.2011.11. Epub 2011 Feb 21.

    PMID:
    21339736
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk